TGFB1 and infection: The compound’s unique triple-mechanism approach—inhibiting viral entry via TGF-β/Smad signaling modulation, disrupting ORF3a-mediated lysosomal dysfunction affecting assembly and egress, and attenuating TGF-β-induced apoptosis during late-stage infection—provides multiple barriers against viral replication while minimizing resistance development.